Skip to content

Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture in Laparoscopic Surgery

A Multicenter, Randomized, Single-blinded, Active Controlled, Non-inferiority, Post Marketing Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture Compared to Quill MonodermTM Suture in Laparoscopic Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05645809
Enrollment
98
Registered
2022-12-12
Start date
2022-11-03
Completion date
2023-09-30
Last updated
2022-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Hysterectomy

Brief summary

Clinical Trial to Evaluate the Safety and Efficacy of MONOFIX® PGCL Suture Compared to Quill MonodermTM Suture in Laparoscopic Surgery

Interventions

DEVICEMONOFIX® PGCL

An absorbable suture made of polyglycapron (PGCL) used for soft tissue suture.

DEVICEQuill Monoderm™

An absorbable suture made of polyglactin used for soft tissue suture.

Sponsors

Samyang Biopharmaceuticals Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1\. Patients scheduled for hysterectomy by laparoscopic surgery * Patients who are scheduled to undergo hysterectomy after being diagnosed with benign tumors in the uterus, including uterine myoma, according to the medical judgment of the investigator * Laparoscopic surgery includes general laparoscopic surgery and robotic surgery.)

Exclusion criteria

1. Patients with contaminated wounds 2. Diseases that may affect wound healing 3. When gynecological malignancy or intra-abdominal metastasis is confirmed at the time of enrollment

Design outcomes

Primary

MeasureTime frameDescription
Time used for suturing the surgical site during laparoscopic hysterectomy0DayTime used from when the first suture is started to when the last suture is finished and the suture is cut

Countries

South Korea

Contacts

Primary ContactMiryung Jin
miryung.jin@samyang.com+82 2 2157 9961

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026